Magnitude Biosciences is a specialist Contract Research Organisation (CRO) and one of the world’s leading C. elegans and automated imaging experts.
Magnitude Biosciences shares the vision of bringing the benefits of this unique research approach to industry, helping to play a part in accelerating the development of new drug therapies and other research advances to improve human and environmental health. Although there are many C. elegans academic labs around the world, there are very few commercial labs that exist to apply the benefits of C. elegans research to the biotechnology and consumer goods industries.
Magnitude Biosciences helps biotechnology companies, pharmaceutical companies, health products companies, manufacturing (including agri-manufacturing and green manufacturing) and anyone else doing Research and Development (R&D) who can benefit from our C. elegans health span technology and expertise. Our key research areas include early preclinical drug discovery projects, microbiome, ageing, neurodegeneration and neurodegenerative diseases, environmental toxicity, reproductive toxicity, and C. elegans transgenics.